Expression of c-Fes protein isoforms correlates with differentiation in myeloid leukemias

DNA and Cell Biology

Volumn 24, Issue 5, 2005, Pages 311-316

  Carlson, Anne ^a   Berkowitz, Jeanne McAdara ^a   Browning, Damaris ^a   Slamon, Dennis J ^a   Gasson, Judith C ^a   Yates, Karen E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; MESSENGER RNA; PROTEIN P62; PROTEIN P67; PROTEIN P93; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; BLAST CELL; BONE MARROW CELL; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CHRONIC MYELOID LEUKEMIA; CORRELATION ANALYSIS; ENZYME SPECIFICITY; EXON; FES GENE; GENE DELETION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MOUSE; MYELOID LEUKEMIA; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTIGENS, CD34; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEMATOPOIETIC STEM CELLS; HL-60 CELLS; HUMANS; IMMUNOBLOTTING; K562 CELLS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MICE; NEUTROPHILS; NIH 3T3 CELLS; POLYMERASE CHAIN REACTION; PROTEIN ISOFORMS; PROTO-ONCOGENES; RNA, MESSENGER; U937 CELLS;

ANIMALIA;

EID: 18544375921     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2005.24.311     Document Type: Article

References (37)

1. ASPENSTROM, P. (1997). A cdc42 target protein with homology to the non-kinase domain of fer has a potential role in regulating the actin cytoskeleton. Curr. Biol. 7, 479-487.
2. BLACK, D.L. (2000). Protein diversity from alternative splicing: A challenge for bioinformatics and post-genome biology. Cell 103, 367-370.
3. BRETT, D., HANKE, J., LEHMANN, G., HAASE, S., DELBRUCK, S., KRUEGER, S., REICH, J., and BORK, P. (2000). Est comparison indicates 38% of human mrnas contain possible alternative splice forms. FEBS Lett. 474, 83-86.
4. CARE, A., MATTIA, G., MONTESORO, E., PAROLINI, I., RUSSO, G., COLOMBO, M.P., and PESCHLE, C. (1994). C-fes expression in ontogenetic development and hematopoietic differentiation. Oncogene 9, 739-747.
5. EASTY, D.J., GANZ, S.E., FARR, C.J., LAI, C., HERLYN, M., and BENNETT, D.C. (1993). Novel and known protein tyrosine kinases and their abnormal expression in human melanoma. J Invest Dermatol 101, 679-684.
6. EVINGER-HODGES, M.J., DICKE, K.A., GUTTERMAN, J.U., and BLICK, M. (1987). Proto-oncogene expression in human normal bone marrow. Leukemia 1, 597-602.
7. FELDMAN, R.A., GABRILOVE, J.L., TAM, J.P., MOORE, M.A., and HANAFUSA, H. (1985). Specific expression of the human cellular fps/fes-encoded protein ncp92 in normal and leukemic myeloid cells. Proc. Natl. Acad. Sci. USA 82, 2379-2383.
8. FERRARI, S., TORELLI, U., SELLERI, L., DONELLI, A., VENTURELLI, D., MORETTI, L., and TORELLI, G. (1985). Expression of human c-fes one-gene occurs at detectable levels in myeloid but not in lymphoid cell populations. Br. J. Haematol. 59, 21-25.
9. GLAZER, R.I., CHAPEKAR, M.S., HARTMAN, K.D., and KNODE, M.C. (1986). Appearance of membrane-bound tyrosine kinase during differentiation of hl-60 leukemia cells by immune Interferon and tumor necrosis factor. Biochem. Biophys. Res. Commun. 140, 905-915.
10. GOLDMAN, J., and MCGUIRE, W.A. (1992). Oncogene rna expression in three human lymphoblastic leukemia cell lines lymphocytes. Pediatr. Hematol. Oncol. 9, 57-63.
11. GRAVELEY, B.R. (2001). Alternative splicing: Increasing diversity in the proteomic world. Trends Genet. 17, 100-107.
12. GREER, P., HAIGH, J., MBAMALU, G., KHOO, W., BERNSTEIN, A., and PAWSON, T. (1994). The fps/fes protein-tyrosine kinase promotes angiogenesis in transgenic mice. Mol. Cell Biol. 14, 6755-6763.
13. HACKENMILLER, R., and SIMON, M.C. (2002). Truncation of c-fes via gene targeting results in embryonic lethality and hyperproliferation of hematopoietic cells. Dev. Biol. 245, 255-269.
14. HACKENMILLER, R., KIM, J., FELDMAN, R.A., and SIMON, M.C. (2000). Abnormal stat activation, hematopoietic homeostasis, and innate immunity in c-fes-/- mice. Immunity 13, 397-407.
15. HAIGH, J., MCVEIGH, J., and GREER, P. (1996). The fps/fes tyrosine kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells and is localized in the trans-Golgi network. Cell Growth Differ. 7, 931-944.
16. HANKE, J., BRETT, D., ZASTROW, I., AYDIN, A., DELBRUCK, S., LEHMANN, G., LUFT, F., REICH, J., and BORK, P. (1999). Alternative splicing of human genes: More the rule than the exception? Trends Genet. 15, 389-390.
17. JUCKER, M., ROEBROEK, A.J., MAUTNER, J., KOCH, K., EICK, D., PIEHL, V., VAN DE VEN, W.J., and TESCH, H. (1992). Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines. Oncogene 7, 943-952.
18. KARTHAUS, H.F., SCHALKEN, J.A., FEITZ, W.F., DEBRUYNE, P.M., DE HAAN, P.T., BLOEMERS, H.P., and VAN DE VEN, W.J. (1986). Expression of the human fes cellular oncogene in renal cell tumors. Urol. Res. 14, 123-127.
19. KIM, J., and FELDMAN, R.A. (2002). Activated fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (u937 cells) and activation of the transcription factor pu.1. Mol. Cell Biol. 22, 1903-1918.
20. KIM, J., OGATA, Y., and FELDMAN, R.A. (2003). Fes tyrosine kinase promotes survival and terminal granulocyte differentiation of factor-dependent myeloid progenitors (32d) and activates lineage-specific transcription factors. J. Biol. Chem. 278, 14978-14984.
21. KIM, J., OGATA, Y., ALI, H., and FELDMAN, R.A. (2004). The fes tyrosine kinase: A signal transducer that regulates myeloid-specific gene expression through transcriptional activation. Blood Cells Mol. Dis. 32, 302-308.
22. LANFRANCONE, L., MANNONI, P., PEBUSQUE, M.J., CARE, A., PESCHLE, C., GRIGNANI, F., and PELICCI, P.O. (1989). Expression pattern of c-fes oncogene mrna in human myeloid cells. Int. J. Cancer Suppl. 4, 35-38.
23. MACDONALD, I., LEVY, J., and PAWSON, T. (1985). Expression of the mammalian c-fes protein in hematopoietic cells and identification of a distinct fes-related protein. Mol. Cell Biol. 5, 2543-2551.
24. MANFREDINI, R., GRANDE, A., TAGLIAFICO, E., BARBIERI, D., ZUCCHINI, P., CITRO, G., ZUPI, G., FRANCESCHI, C., TORELLI, U., and FERRARI, S. (1993). Inhibition of c-fes expression by an antisense oligomer causes apoptosis of hl60 cells induced to granulocytic differentiation. J. Exp. Med. 178, 381-389.
25. MANFREDINI, R., BALESTRI, R., TAGLIAFICO, E., TREVISAN, F., PIZZANELLI, M., GRANDE, A., BARBIERI, D., ZUCCHINI, P., CITRO, G., FRANCESCHI, C., and FERRARI, S. (1997). Antisense inhibition of c-fes proto-oncogene blocks pma-induced macrophage differentiation in hl60 and in fdc-p1/mac-11 cells. Blood 89, 135-145.
26. NISHIO, H., NAKAMURA, S., HORAI, T., IKEGAMI, H., and MATSUDA, M. (1992). Clinical and histopathologic evaluation of the expression of ha-ras and fes oncogene products in lung cancer. Cancer 69, 1130-1136.
27. READ, R.D., LIONBERGER, J.M., and SMITHGALL, T.E. (1997). Oligomerization of the fes tyrosine kinase. Evidence for a coiled-coil domain in the unique n-terminal region. J. Biol. Chem. 272, 18498-18503.
28. SANGRAR, W., GAO, Y., ZIRNGIBL, R.A., SCOTT, M.L., and GREER, P.A. (2003). The fps/fes proto-oncogene regulates hematopoietic lineage output. Exp. Hematol. 31, 1259-1267.
29. SENIS, Y., ZIRNGIBL, R., MCVEIGH, J., HAMAN, A., HOANG, T., and GREER, P.A. (1999). Targeted disruption of the murine fps/fes proto-oncogene reveals that fps/fes kinase activity is dispensable for hematopoiesis. Mol. Cell Biol. 19, 7436-7446.
30. SENIS, Y.A., CRAIG, A.W., and GREER, P.A. (2003). Fps/fes and fer protein-tyrosinekinases play redundant roles in regulating hematopoiesis. Exp. Hematol. 31, 673-681.
31. SLAMON, D.J., DEKERNION, J.B., VERMA, I.M., and CLINE, M.J. (1984). Expression of cellular oncogenes in human malignancies. Science 224, 256-262.
32. SMITHGALL, T.E., YU, G., and GLAZER, R.I. (1988). Identification of the differentiation-associated p93 tyrosine protein kinase of hl-60 leukemia cells as the product of the human c-fes locus and its expression in myelomonocytic cells. J. Biol. Chem. 263, 15050-15055.
33. STONE, J.C., ATKINSON, T, SMITH, M., and PAWSON, T. (1984). Identification of functional regions in the transforming protein of fujinami sarcoma virus by in-phase insertion mutagenesis. Cell 37, 549-558.
34. TAGLIAFICO, E., SIENA, M., ZANOCCO-MARANI, T., MANFREDINI, R., TENEDINI, E., MONTANARI, M., GRANDE, A., and FERRARI, S. (2003). Requirement of the coiled-coil domains of p92(c-fes) for nuclear localization in myeloid cells upon induction of differentiation. Oncogene 22, 1712-1723.
35. WALKER, L., LYNCH, M., SILVERMAN, S., FRASER, J., BOULTER, J., WEINMASTER, G., and GASSON, J.C. (1999). The notch/jagged pathway inhibits proliferation of human hematopoietic progenitors in vitro. Stem Cells 17, 162-171.
36. YATES, K.E., LYNCH, M.R., WONG, S.G., SLAMON, D.J., and GASSON, J.C. (1995). Human c-fes is a nuclear tyrosine kinase. Oncogene 10, 1239-1242.
37. YU, G., and GLAZER, R.I. (1987). Purification and characterization of p93fes- and p60src-related tyrosine protein kinase activities in differentiated hl-60 leukemia cells. J. Biol. Chem. 262, 17543-17548.